Cyclophosphamide treatment-induced leukopenia rates in ANCA-associated vasculitis are influenced by variant CYP450 2C9 genotypes (Q40785035)

23 September 2017

title

Cyclophosphamide treatment-induced leukopenia rates in ANCA-associated vasculitis are influenced by variant CYP450 2C9 genotypes (English)

1 reference

23 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26894931%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Ingolf Cascorbi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26894931%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

Jan Phillip Bremer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26894931%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Frank Moosig

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26894931%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Julia Ulrike Holle

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26894931%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Peter Lamprecht

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26894931%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Stefan Wieczorek

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26894931%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Sierk Haenisch

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26894931%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

publication date

19 February 2016

1 reference

23 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26894931%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26894931%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26894931%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

367-374

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26894931%20AND%20SRC:MED&resulttype=core&format=json

2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

13 June 2020

cites work

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.176

EULAR recommendations for the management of primary small and medium vessel vasculitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.176

Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.176

Wegener Granulomatosis: An Analysis of 158 Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.176

An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.176

Rituximab versus cyclophosphamide for ANCA-associated vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.176

Efficacy of remission-induction regimens for ANCA-associated vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.176

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.176

Antimycotic drug discovery in the age of genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.176

Relationship of drug metabolizing enzyme genotype to plasma levels as well as myelotoxicity of cyclophosphamide in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.176

Significant role of CYP450 genetic variants in cyclophosphamide based breast cancer treatment outcomes: a multi-analytical strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.176

Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.176

EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.176

Genotype frequencies of selected drug metabolizing enzymes and ABC drug transporters among breast cancer patients on FAC chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.176

Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.176

Cyclophosphamide and 4-hydroxycyclophosphamide pharmacokinetics in patients with glomerulonephritis secondary to lupus and small vessel vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.176

Relations between polymorphisms in drug-metabolising enzymes and toxicity of chemotherapy with cyclophosphamide, thiotepa and carboplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.176

BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.176

Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.15.176